Increasing resistance to multiple anthelmintic classes in gastrointestinal nematodes on sheep farms in southwest England.

BACKGROUND: Anthelmintic resistance (AR) in gastrointestinal nematodes (GIN) is increasing globally, and farmers are encouraged to adopt sustainable control measures. Haemonchus contortus is increasingly reported in the UK, potentially complicating effective GIN control. METHODS: Faecal egg count reduction tests (FECRT) were conducted on 13 farms in north Devon, England, UK in 2016. Relative abundance of H. contortus was quantified using peanut agglutinin staining and used to estimate faecal egg count reduction percentages (FECR%) using the eggCounts R package. RESULTS: On average, farms had GIN resistance to three anthelmintic classes. No farms had susceptibility to all anthelmintics tested. AR was more prevalent in 2016 than on the same farms in 2013. H. contortus was present on 85% of the farms tested and comprised on average 6% (0%-52%) of GIN eggs before treatment. Resistance or suspected resistance to all anthelmintics tested was observed in this species on different farms. CONCLUSION: The results demonstrate diversity of AR profiles on farms, apparent progression of AR within a 3-year period, and challenges detecting AR in mixed-species infections. Where possible, interpretation of mixed-species FECRT should take into account the relative abundance of species pre- and post-treatment to identify pragmatic treatment options targeting individual genera.

Highs and Lows of Lambing Time: Sheep Farmers' Perceptions of the First Outbreak of Schmallenberg Disease in South West England on Their Well-Being.

The outbreak of a previously unknown and new disease in the United Kingdom, known as 'Schmallenberg disease', a disease associated with abortions, stillbirths and fetal deformities in naïve ewes, was reported for the first time in South West England during the 2012/13 early lambing season. Epidemiological studies confirmed that the Schmallenberg virus (SBV) had a severe negative impact upon animal welfare and the productivity of affected flocks. By contrast, there was a specific lack of research on the impact of SBV on sheep farmer well-being. This study aimed to improve our understanding of sheep farmers' experiences of Schmallenberg disease, and the impact of the first outbreak on sheep farmer well-being during the 2012/13 early lambing season in South West England. Face-to-face, semi-structured interviews with six farmers with small flocks of pedigree and purebred sheep in South West England were conducted in 2013. The data were analysed via thematic analysis. The main themes regarding the impact of disease on farmer well-being included: (i) emotional highs and lows are part of a normal lambing season; (ii) negative emotions and memories associated with the Schmallenberg disease outbreak; and (iii) resilience and coping with the unexpected disease outbreak. These novel data present preliminary findings from a small number of sheep farmers, and indicate that for some farmers, an unexpected outbreak of a new and emerging disease for the first time during lambing, and dealing with high levels of dystocia, deformities and deaths in their animals, had a negative impact on their emotional well-being during the peak period of the sheep production cycle.

Resistance delaying strategies on UK sheep farms: A cost benefit analysis.

UK guidelines for the sustainable control of parasites in sheep (SCOPS) were formulated with the primary aim of delaying development of anthelmintic resistance (AR) on UK sheep farms. Promoting their use requires the engagement and commitment of stakeholders. An important driver for behavioural change in sheep farmers is evidence of economic benefits. A recent evaluation of SCOPS guidance in practice demonstrated a significant reduction in anthelmintic use, suggesting economic benefits through a direct reduction in product and labour costs. However, in order to maintain production, a range of alternative control strategies are advised, resulting in additional costs to farmers and so a full cost benefit analysis of best practice management was undertaken. We allocated financial values to the management recommendations described in the SCOPS technical manual. Benefits were calculated using data for production variables and anthelmintic use measured during studies to evaluate the effect of SCOPS recommendations on 16 UK sheep farms and from other published work. As SCOPS control is not prescriptive and a range of different diagnostics are available, best and worst case scenarios were presented, comparing the cheapest methods (e.g. egg counts without larval culture) and management situations (e.g closed flocks not requiring quarantine treatments) with the most laborious and expensive. Simulations were run for farms with a small, medium or large flock (300; 1000; 1900 ewes) as well as comparing scenarios with and without potential production benefits from using effective wormers. Analysis demonstrated a moderate cost for all farms under both scenarios when production benefits were not included. A cost benefit was demonstrated for medium and large farms when production benefits were included and the benefit could be perceived as significant in the case of the large farms for the best case scenario (>£5000 per annum). Despite a significant potential reduction in anthelmintic use by farmers employing SCOPS guidance, the very low price of the older anthelmintic classes meant that the benefit did not always outweigh the additional management/diagnostic costs unless an increase in production was also achieved. This is an important finding. Focussing research on key innovations that will improve the cost effectiveness of diagnostic assays in a diagnostic driven control strategy, as well as designing treatment options that can improve production outcomes, and presenting them in a clear and transparent way, must be high priority goals. Coupling targeted research with improvements in the delivery of messages to the end user is important in the light of increasing global concerns over drug resistance.